Lab-Grown Meat Ka Khazana: Paisa aa raha hai, approve bhi ho raha hai, par road aasan nahi!

TECH
Whalesbook Logo
AuthorRiya Kapoor|Published at:
Lab-Grown Meat Ka Khazana: Paisa aa raha hai, approve bhi ho raha hai, par road aasan nahi!
Overview

Arey bhaiyo, yeh cultivated meat wala industry na ab kamaal macha raha hai! Bada-bada paisa aa raha hai aur lab-grown food ko approve bhi kar rahe hain. Wildtype aur Eat Just jaise players iss field mein zabardast kaam kar rahe hain. Lekin asli picture thodi complex hai, kyunki conventional meat ke price tak pahunchna aur logo ka trust jeetna, yeh sab bada challenge hai. Research aur cost cut karna bahut zaroori hai.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Yeh jo lab mein meat banane ka idea tha na, jo pehle sirf science fiction lagta tha, woh ab real ho raha hai. Cellular agriculture ka ek bada part, cultivated meat sector, ab bohot tezi se grow kar raha hai aur investment bhi aa rahi hai. Isse hum food production ko badal sakte hain. Biotech ka use karke, jaise precision fermentation aur cell culture se, yeh log meat, seafood, aur dairy alternatives bana rahe hain. Goal hai ki farming ke environmental aur ethical issues solve ho sakein. Duniya bhar mein 142 se zyada companies iss field mein kaam kar rahi hain.

Investors ka trust cultivated meat par kaafi badh raha hai, jisse bade funding rounds ho rahe hain. Wildtype, jo cell-cultured seafood banati hai, usne 2022 mein $100 million raise kiye. UPSIDE Foods ne April 2022 mein $400 million ka Series C round complete kiya aur company ki valuation $1 billion se upar gayi. Eat Just ne total $850 million se zyada raise kiye hain, jisme March 2021 ka $200 million round bhi shamil hai. Mosa Meat, jinhone pehla cultivated beef burger banaya tha, woh bhi nayi funding ke saath aage badh rahe hain. Aur haan, US ne June 2023 mein UPSIDE Foods aur Eat Just ke GOOD Meat division ke cultivated chicken ko approve kar diya hai. Singapore, Australia, New Zealand aur Israel ne bhi cultivated meat bechne ke liye processes bana liye hain.

Cellular agriculture market 2033 tak $786 billion tak pahunch sakta hai. Iska reason hai sustainability ko lekar awareness aur logo ki badalti dietary habits. North America aur Asia-Pacific mein iska growth zyada dekha ja raha hai. Technology ki baat karein toh, bioreactor design, cell cultivation aur serum-free growth media mein advancements se production costs kam honge aur efficiency badhegi. McKinsey ka kehna hai ki cultivated chicken ki price conventional meat ke barabar 2030 tak ho sakti hai, around £4.90 per kilogram.

Lekin bhai, sab itna aasan nahi hai. Sabse bada hurdle hai production ko scale up karna aur costs kam karna. Growth media, bioreactor operations, aur clean room facilities ke kharche kam karne honge. Currently, cultivated meat ka cost per kilogram $63/kg ke aas paas hai large-scale output ke liye, jo ki pehle ke prototypes ke millions per kilogram ke muqable mein kam hai, par abhi bhi bahut zyada hai. Bioreactor technology ko pharmaceutical standards se adapt karke food industry ki needs ke hisab se badalna hoga, jisme kafi investment aur complexity hai.

Consumer perception bhi ek bada issue hai. Surveys mein logo ko cultivated meat swaad aur health ke mamle mein conventional meat se kam lagta hai, aur iski 'unnaturalness' unhe hesitate karti hai. Marketing se farak pad sakta hai, par iski novelty ke karan kai logo ko iska experience nahi hai. Taste aur texture mein improvement ki demand hai aur technology ko lekar bhi kuch skepticism hai. Environment ke benefit bhi clear nahi hain. Agar facilities renewable energy se nahi chalti, toh carbon footprint conventional chicken jaisa ya usse zyada ho sakta hai. Regulatory approvals mein bhi challenges hain, jaise Eat Just ka ABEC Inc. ke saath pehle ka dispute. Isko plant-based alternatives se bhi compete karna padega jo saste hain.

Cultivated meat industry ek critical point par hai. Regulatory approvals aur investment progress dikha rahe hain, par widespread commercialization ka rasta lamba aur challenges se bhara hai. Market ka success is par depend karega ki industry cost barriers kaise overcome karti hai, taste aur texture ko improve karti hai, aur apne benefits clear kar paati hai. Ambitious growth forecasts tabhi poori hongi jab bioprocessing mein bade innovations honge aur consumer acceptance badhegi.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.